Form 603, “Notice of initial substantial holder” was lodged with the Australian Securities Exchange on 30th January at 5:25 PM.
View the Form 603.
Positive Final Results of Wayne State Collaboration Drives Completion of Phase 2 Study Protocol for IND Submission to FDA in December
December 2, 2025
Positive Final Results of Wayne State Collaboration Drives Completion of Phase 2 Study Protocol for IND Submission to FDA in December Key Highlights: MagSense® HER2